About Omeros Corp.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

At the moment the company generates 22M USD in revenues.

On its last earning announcement, the company reported a loss of -2.47$ per share.

The book value per share is -1.15$

Omeros Corp. website

Create a solid portfolio with OMER

Add OMER to your portfolio and optimize it!


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
22M 96.20% -108M -499.10% -120M -2.47 - - 48M -1.15 -83M - -84M